Honey segment loss blew out to NZ$15.3m as PBT deficit widened 24%

What changed

Revenue grew 14.6% to NZ$8.3m, with gross margin edging up roughly 108bps to 38.0%. Below that line, every profitability measure deteriorated: EBITDA loss widened 32.5% to NZ$5.7m, operating loss deepened 49.0% to NZ$8.8m, and PBT loss expanded 24.4% to NZ$22.1m. NPAT loss of NZ$19.5m was only 9.8% worse than prior year, but that shallower decline is entirely attributable to NZ$2.6m of tax benefit (an 11.8% effective rate) versus no tax line in FY20 — PBT is the cleaner operating read.

Operating cash outflow widened to NZ$11.7m from NZ$9.6m. Despite that, cash on hand rose to NZ$5.4m from NZ$1.1m and equity increased NZ$5.0m, indicating a capital injection rather than operational funding. Gross borrowings were broadly flat at NZ$12.2m, leaving reported net debt lower at NZ$6.9m.

Segment mix tells the real story: the honey division (60.7% of revenue) produced a segment result of –NZ$15.3m versus –NZ$1.2m prior, a roughly twelvefold deterioration that drives essentially all of the incremental loss.

What matters

• Honey segment collapse. Honey revenue actually grew modestly to NZ$5.0m, yet the segment result of –NZ$15.3m implies a margin of approximately –304%. That magnitude is inconsistent with trading losses alone and is consistent with an inventory-linked charge against the 630 tonnes of Mānuka stock management is trying to sell down. The filing does not quantify a specific writedown in the extracted data, so the driver is disclosed only at segment-result level.
• Cash burn versus liquidity. Cash rose only because equity was raised; operating cash burn accelerated and free cash flow pre-lease was –NZ$12.1m against a cash balance of NZ$5.4m. The runway implied by the current burn rate is short without further funding or a material honey sell-down.
• Stated strategy is inventory liquidation. Management explicitly points to selling honey stocks through brand investment (jar sales) and opportunistic drum/wholesale sales. That is a volume-and-price problem the balance sheet has already partly recognised through the honey segment result.

Expectations

No quantitative targets or forward-work figures were disclosed in the extracted materials, so the result cannot be benchmarked against company guidance. Seasonality is sharply second-half weighted: HY21 revenue was only NZ$0.4m (5.1% of the full year), implying ~NZ$7.8m of 2H revenue, and HY21 NPAT loss of NZ$1.3m was only 6.4% of the full-year loss. That shape means the bulk of both the revenue and the deterioration landed in 2H, which limits confidence in extrapolating either direction from first-half prints in future periods.

Quality of result

Low durability. The 14.6% revenue improvement and 108bps gross margin expansion are real but small in absolute terms (NZ$0.5m of additional gross profit), and they are dwarfed by a NZ$14.1m worsening in the honey segment result that looks balance-sheet-driven rather than trading-driven. Cash conversion deteriorated directly: operating cash outflow grew 21.9% against only a 32.5% widening in EBITDA loss, and OCF/EBITDA stayed at roughly 2.1x — i.e., cash burn is structurally larger than accounting EBITDA loss because working capital (particularly 1,195 days of inventory) continues to tie up capital. The headline improvement in net debt is funded by fresh equity, not operations.

Unresolved

• Is the honey segment loss driven by an inventory impairment, a write-down to net realisable value, or onerous contracts — and how much of the 630 tonnes has been marked?
• What price realisation is being achieved on current drum-honey wholesale sales versus carrying value?
• What is the expected cash runway given the NZ$11.7m annual burn and NZ$5.4m closing cash, and what further funding is contemplated?
• What are the covenant positions on the NZ$7.0m bank loans and NZ$5.2m subordinated note given sustained losses?
• No forward revenue, margin, or inventory sell-down target was disclosed, so the pace of the stated strategy is not testable.

This briefing cannot assess the underlying recoverable value of the 630-tonne honey inventory or the adequacy of current liquidity against any unstated funding plan.

Key metrics

Segment breakdown

Analytical metrics

---

This analysis was generated using Annolyse, an AI-powered tool that analyses NZX/ASX company announcements. The analysis is based on available company filings and standard Annolyse calculations. This is general information only and does not constitute financial advice. The analysis may contain errors. Always read the original company filings and consult a licensed financial adviser before making investment decisions.